| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de71996d1afb7567526b22ff2728b0ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36e431d7f8d5e3c88a7b69898c6a23fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a11fb55bfab4265ffc0ab054c9656e69 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T29-49572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14276
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H04R2460-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H04R25-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H04R25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H04R25-606 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F11-04 |
| filingDate |
2009-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8bcd185116e2d490f5ea9e0507ed249
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_043aff1e6a39d0effcc1ac87ab47e6eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b0bf4ec6e16e3ecce9b8f1c6f7a11ec |
| publicationDate |
2011-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011112462-A1 |
| titleOfInvention |
Pharmaceutical agent delivery in a stimulating medical device |
| abstract |
A stimulating medical device comprising a stimulating assembly implantable proximate to nerve cells of a recipient having at least one agent delivery port and a plurality of electrical contacts; an electrical stimulation controller configured to generate electrical stimulation signals for application to a first population of the nerve cells via one or more of the plurality of electrical contacts; a pharmaceutical agent source configured to provide a pharmaceutical agent to the at least one delivery port for application to a second population of the nerve cells; and a pharmaceutical agent controller configured to control one or more of the pharmaceutical agent source and the at least one delivery port to cause selective application of the pharmaceutical agent to the second population of nerve cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10863286-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10034103-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10306381-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10284964-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11212626-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019058330-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11483665-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11743663-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10609492-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11540065-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11337012-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020238062-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10237663-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11350226-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10743110-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10511913-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10516946-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10516949-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10516950-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10516951-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11166114-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10531206-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3684311-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10154352-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11259129-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11317224-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11057714-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10492010-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11058305-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11310605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10779094-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11516603-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11252516-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017095202-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10292601-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11102594-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11153697-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11070927-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11516602-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11671774-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10178483-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11564044-B2 |
| priorityDate |
2008-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |